Status | Study |
Active, not recruiting |
Study Name: Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leuk Date: 2013-07-17 Interventions: Drug: lenalidomide Given PO |
Active, not recruiting |
Study Name: Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leuk Date: 2013-06-04 Interventions: Other: antitumor drug screening assay |
Completed |
Study Name: Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia Condition: Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Date: 2013-06-03 Interventions: Drug: Cytarabine Given IV |
Active, not recruiting |
Study Name: Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leuk Date: 2013-05-06 Interventions: Drug: metformin hydrochloride |
Active, not recruiting |
Study Name: Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Date: 2013-04-19 Interventions: Drug: azacitidine Given IV or |
Withdrawn |
Study Name: Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leuk Date: 2013-04-15 Interventions: Drug: arsenic trioxide Given I |
Completed |
Study Name: Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leuk Date: 2013-04-08 Interventions: Drug: pravastatin sodium Given |
Completed |
Study Name: Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Date: 2013-03-26 Interventions: Drug: tretinoin Given PO |
Active, not recruiting |
Study Name: Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Date: 2013-03-25 Interventions: Drug: Sirolimus Given PO |
Recruiting |
Study Name: Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Date: 2013-02-26 Interventions: Drug: mitoxantrone hydrochloride |